Article Text

other Versions

PDF
Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease
  1. Rie Tanaka1,
  2. Hiroshi Murata1,
  3. Mitsuko Takamoto1,
  4. Kazuyoshi Ohtomo1,
  5. Kimiko Okinaga1,
  6. Atsushi Yoshida2,
  7. Hidetoshi Kawashima2,
  8. Hisae Nakahara1,
  9. Yujiro Fujino3,
  10. Toshikatsu Kaburaki1
  1. 1Department of Ophthalmology, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan
  2. 2Department of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi, Japan
  3. 3Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Shinjyuku-ku, Tokyo, Japan
  1. Correspondence to Dr Rie Tanaka, Department of Ophthalmology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; rtanaka-ymn{at}umin.ac.jp

Abstract

Aims To investigate the ability of the Behçet's disease ocular attack score 24 (BOS24) scoring system to predict visual acuity (VA) in patients with ocular Behçet's disease.

Design This is a retrospective study.

Methods We included 91 eyes of 50 patients with ocular Behçet's disease (33 males, 17 females) who were referred to our hospital between 1986 and 2008 with >5 years follow-up. Total BOS24 scores over a 5-year period, BOS24-5Y, were calculated as the sum of BOS24 scores for each attack over the 5-year study period for each eye. Change in VA was defined as change in best-corrected visual acuity (BCVA) from the first remission to the last remission at the end of the target period. Factors related to change in VA (age, gender, BCVA at the first remission, total number of immunosuppressive medications and total number of ocular attacks during the 5-year period and BOS24-5Y) were evaluated using a linear mixed model.

Results BCVA (logarithm of the minimal angle resolution) deteriorated from 0.16±0.30 (mean±SD) to 0.21±0.37 over the 5-year study period, but there was no statistical difference. The total number of ocular attacks during the 5-year period and BOS24-5Y scores were 10.0±7.9 and 36.8±40.8, respectively. Linear mixed-model analysis revealed that BOS24-5Y was the most important index for VA deterioration, followed by BCVA at the first remission.

Conclusions BOS24-5Y was found to be a significant positive prognostic index for VA deterioration in patients with ocular Behçet's disease.

  • Inflammation
  • Immunology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton Jost Jonas James Chodosh